NERVOUS SYSTEM DISEASES
Clinical trials for NERVOUS SYSTEM DISEASES explained in plain language.
Never miss a new study
Get alerted when new NERVOUS SYSTEM DISEASES trials appear
Sign up with your email to follow new studies for NERVOUS SYSTEM DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets brain inflammation to slow Alzheimer's
Disease control CompletedThis study tested an experimental drug called XPro1595 in 208 people with early Alzheimer's disease who also had signs of brain inflammation. The goal was to see if the drug could improve memory, thinking, and daily function compared to a placebo over 24 weeks. Researchers also c…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New device aims to pull clots from the brain in major strokes
Disease control CompletedThis completed study tested a new device called the Supernova stent retriever in 55 people with severe stroke caused by a large blood clot in the brain. The device is threaded through blood vessels to grab and remove the clot, restoring blood flow. Researchers measured how often …
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: NA • Sponsor: Gravity Medical Technology, INC • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Friends and family may be key to preventing second strokes
Disease control CompletedThis study tested whether using social networks (like family and friends) can help people at high risk for stroke stick to their medications and control risk factors after leaving the hospital. Researchers enrolled 720 patients and compared standard care with a social network-bas…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: NA • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug aims to help boys with duchenne walk longer
Disease control CompletedThis study tested a drug called ataluren in 360 boys with Duchenne muscular dystrophy caused by a specific genetic mistake (nonsense mutation). The main goal was to see if ataluren could help them walk farther over 72 weeks compared to a placebo. All participants were also taking…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Brain surgery infection fighter: vancomycin powder put to the test
Disease control CompletedThis study tested whether applying vancomycin powder directly to the surgical wound during brain surgery can reduce infections. Over 1,100 adults having neurosurgery were randomly assigned to receive either the topical vancomycin or standard care. The main goal was to see if the …
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: PHASE3 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Experimental drug AOC 1001 tested for Long-Term safety in rare muscle disease
Disease control CompletedThis study is a follow-up to an earlier trial, testing the long-term safety and effects of a drug called AOC 1001 in adults with myotonic dystrophy type 1 (DM1), a genetic muscle disease. 37 participants who completed the first study received multiple doses of AOC 1001 by IV infu…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a High-Tech suit soothe fibromyalgia pain?
Symptom relief CompletedThis study tested whether a special suit called EXOPULSE Mollii can help adults with fibromyalgia feel less pain, fatigue, and depression. Twenty-eight participants wore either the active suit or a sham (fake) suit for two weeks, then had a washout period. After that, everyone co…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: NA • Sponsor: Sheikh Shakhbout Medical City • Aim: Symptom relief
Last updated Jun 26, 2026 15:18 UTC
-
Robot arm trainer shows promise for kids with nerve conditions
Knowledge-focused CompletedThis study tested a new robot called ChARMin designed to help children with arm weakness due to nervous system diseases. 63 children aged 5 to 21 used the robot to play games that encouraged arm movement. The goal was to see if the robot was safe, easy to use, and could measure p…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: NA • Sponsor: Huub van Hedel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Eye camera spots hidden inflammation in MS patients
Knowledge-focused CompletedThis study used a special eye camera (adaptive optics) to look at blood vessel inflammation in the retina of 50 people with multiple sclerosis (MS) and healthy volunteers. The goal was to see if this inflammation differs between MS types and could serve as an early marker of dise…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Rowing study dives deep into Athletes' inner workings
Knowledge-focused CompletedThis study looked at 30 young Polish rowers to understand how their bodies handle intense exercise. Researchers measured hormones, metabolism, and iron levels before and after a 2000-meter rowing test. The goal is to learn more about how athletes adapt to physical strain, not to …
Matched conditions: NERVOUS SYSTEM DISEASES
Sponsor: Poznan University of Physical Education • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:15 UTC